SCHEMBL5118962

SCHEMBL5118962

CCC(=O)Nc1cccc(COc2c(Cl)cc(CC(=O)O)cc2Cl)c1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 9/20 0.53
THRB P10828 9/20 0.53
FABP4 P15090 1/20 0.41
FABP5 Q01469 1/20 0.41
MRGPRX4 Q96LA9 5/20 0.40
ALDH1A1 P00352 3/20 0.40
HPGD P15428 2/20 0.40
MEN1 O00255 1/20 0.40
ABL1 P00519 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
MAPT P10636 1/20 0.40
RAB9A P51151 1/20 0.40
KMT2A Q03164 1/20 0.40
RIN1 Q13671 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
POLB P06746 1/20 0.39
KDM4E B2RXH2 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5722466 0.91 THRA (0.45) THRATHRBFABP4FABP5MRGPRX4
SCHEMBL5109561 0.90 THRA (0.46) THRATHRBALDH1A1HPGDMEN1
SCHEMBL5113345 0.90 THRB (0.50) THRATHRBLMNAMAPT
SCHEMBL5108841 0.89 FABP4 (0.42) THRATHRBFABP4FABP5MRGPRX4
SCHEMBL5117496 0.89 THRA (0.54) THRATHRBFABP4FABP5ALDH1A1
SCHEMBL5107795 0.88 THRA (0.54) THRATHRBFABP4FABP5MRGPRX4
SCHEMBL4933408 0.87 FABP4 (0.42) THRATHRBFABP4FABP5MRGPRX4
SCHEMBL4922999 0.87 MRGPRX4 (0.46) THRATHRBFABP4FABP5MRGPRX4
SCHEMBL5116438 0.86 THRB (0.51) THRATHRBALDH1A1HPGDMEN1
SCHEMBL5112221 0.85 THRB (0.53) THRATHRBALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor KARO BIO AB (SE) 2008-01-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080004251-A1 Novel Pharmaceutical Compositions Comprising Agonists of the Thyroid Receptor TSHR, TRHR, THRA THRA 3/4885THRB 4/4885FABP4 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.